Vista do Intravesical adjuvant therapy with gemcitabine for patients with high-risk non-muscle invasive bladder cancer: Experience from a public hospital in Brazil

Voltar aos Detalhes do Artigo Intravesical adjuvant therapy with gemcitabine for patients with high-risk non-muscle invasive bladder cancer: Experience from a public hospital in Brazil Baixar Baixar PDF